Development of Automated Systems for Cell Therapy.

Area of Science:

• Biotechnology
• Process Engineering
• Cell Therapy Manufacturing

Background:

• Automated systems are crucial for cell therapy manufacturing efficiency and error reduction.
• Current robotic systems (Pharma 3.0) lack process visualization and inventory control, necessitating end-product verification.
• Simple robotic mimicry does not drive innovation in cell manufacturing.

Purpose of the Study:

• To present a quality by design (QbD)-based automated closed-type cell manufacturing system.
• To integrate in-process monitoring for real-time quality assurance.
• To eliminate the post-manufacturing verification step and facilitate industrialization.

Main Methods:

• Development of a closed-type automated cell manufacturing system.
• Implementation of quality by design (QbD) principles.
• Integration of in-process monitoring and data logging.

Main Results:

• The system assures product quality by manufacturing as designed, eliminating the need for pre-shipment verification.
• In-process monitoring provides real-time quality control and process visualization.
• The automated system supports the industrialization and dissemination of cell therapy.

Conclusions:

• A QbD-based automated system with in-process monitoring revolutionizes cell therapy manufacturing.
• This approach ensures product quality and streamlines the production process.
• It is a key step towards the industrialization and widespread adoption of cell therapies.